Tumour necrosis factor blocking agents and progression of subclinical atherosclerosis in patients with ankylosing spondylitis

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)119-123
JournalAnnals of the Rheumatic Diseases
Volume74
Issue number1
DOIs
Publication statusPublished - 2015

Cite this